A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
- PMID: 29491837
- PMCID: PMC5817256
- DOI: 10.3389/fphar.2018.00104
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Abstract
Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F. These compounds exhibit similar pharmacological activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities. Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases. However, toxicity restricts the further development of triptolide and celastrol. In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol. We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivatives. Furthermore, we propose the use of structural derivatives, targeted therapy, and combination treatment as possible solutions to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.
Keywords: Tripterygium wilfordii Hook F; celastrol; mechanisms of action; structure-activity-relationship; triptolide.
Figures
Similar articles
-
A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes.Biomed Pharmacother. 2023 Jun;162:114705. doi: 10.1016/j.biopha.2023.114705. Epub 2023 Apr 14. Biomed Pharmacother. 2023. PMID: 37062220 Review.
-
The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review.Front Med (Lausanne). 2021 Sep 21;8:747922. doi: 10.3389/fmed.2021.747922. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34621768 Free PMC article. Review.
-
The therapeutic potential of triptolide and celastrol in neurological diseases.Front Pharmacol. 2022 Oct 19;13:1024955. doi: 10.3389/fphar.2022.1024955. eCollection 2022. Front Pharmacol. 2022. PMID: 36339550 Free PMC article. Review.
-
Overexpression and RNAi-mediated downregulation of TwIDI regulates triptolide and celastrol accumulation in Tripterygium wilfordii.Gene. 2018 Dec 30;679:195-201. doi: 10.1016/j.gene.2018.08.072. Epub 2018 Sep 5. Gene. 2018. PMID: 30194986
-
Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii.Phytomedicine. 2023 Dec;121:155054. doi: 10.1016/j.phymed.2023.155054. Epub 2023 Sep 2. Phytomedicine. 2023. PMID: 37738906
Cited by
-
Celastrol attenuates renal injury in 5/6 nephrectomized rats via inhibiting epithelial-mesenchymal transition and transforming growth factor-β1/Smad3 pathway.Exp Biol Med (Maywood). 2022 Nov;247(21):1947-1955. doi: 10.1177/15353702221118087. Epub 2022 Sep 1. Exp Biol Med (Maywood). 2022. PMID: 36046983 Free PMC article.
-
Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells.Sci Rep. 2020 Jul 9;10(1):11273. doi: 10.1038/s41598-020-68238-1. Sci Rep. 2020. PMID: 32647287 Free PMC article.
-
Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin.Clin Transl Med. 2022 Apr;12(4):e795. doi: 10.1002/ctm2.795. Clin Transl Med. 2022. PMID: 35384373 Free PMC article. Review.
-
Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma.Acta Pharm Sin B. 2019 May;9(3):575-589. doi: 10.1016/j.apsb.2018.12.009. Epub 2018 Dec 26. Acta Pharm Sin B. 2019. PMID: 31193785 Free PMC article.
-
Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems.Pharmaceutics. 2021 Jan 6;13(1):64. doi: 10.3390/pharmaceutics13010064. Pharmaceutics. 2021. PMID: 33419176 Free PMC article. Review.
References
-
- Astry B., Venkatesha S. H., Laurence A., Christensen-Quick A., Garzino-Demo A., Frieman M. B., et al. (2015). Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ. Clin. Immunol. 157 228–238. 10.1016/j.clim.2015.01.011 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources